Skin Therapy Letter HOME
Written for dermatologists by dermatologists. Indexed by the US National Library of Medicine.
Skin Information
NETWORK
Skin Therapy Letter About STL Subscribe Today SkinCareGuide Network Site Map
CUSTOM DERMATOLOGY SEARCH:
Loading

Derm News: 2007.25(9)

A study evaluating the safety and efficacy of the Velasmooth™ system in the treatment of cellulite

Journal of Cosmetic and Laser Therapy, 9(1):15-20
Neil Sadick, Cynthia Magro
ABSTRACT

Background

Most cellulite treatments are limited in their effectiveness. A combination of radiofrequency energy, infrared light and mechanical manipulation of the skin and fat merits further examination.

Objectives

Subjects were treated with a device combining these energies to evaluate its safety and efficacy.

Methods

Sixteen subjects with cellulite were treated twice weekly for 6 weeks with the VelaSmooth™ system. One thigh was treated while the other served as a control. Treatment efficacy was measured through circumferential measurements of both thighs and by having the investigator and an independent evaluator grade visual improvement during follow-up visits. Five patients provided blood specimens for assessment of lipid and hormone levels and liver function. Two subjects provided three biopsies each in order to monitor the level of estrogen and progesterone receptors.

Results

The overall thigh circumference decreased in 71.87% of the treated legs. The mean decrease was 0.44 cm of the lower thigh and 0.53 cm of the upper thigh. There was significant visual improvement in cellulite and skin texture. At the final follow-up visit, 50% of subjects had greater than 25% improvement (good be very good).

Conclusions

This study showed positive results. Future studies employing higher energy levels and additional treatments will likely augment the results of the present study.


    Back to Current Volume:   Dermatology News 2007.25


The Derm News service provided by the Editorial Consultants of Skin Therapy Letter© and its founding editor Dr. Stuart Maddin.